Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

USANA Health Sciences, Inc. USNA

Consumer Defensive  —  Packaged Foods
14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 16.13 29.74 23.04 17.77 13.16 17.72 15.17 16.50 16.31 35.69
P/S ratio 1.50 1.74 2.39 1.68 1.44 1.72 1.05 1.14 0.80 0.39
P/FCF ratio 14.44 16.50 20.12 16.14 11.22 18.79 11.21 18.66 13.45 29.27
P/Operating CF 27.28 33.10 70.20 31.91 34.04 81.81 25.91 40.28 118.51 (107.33)
P/B ratio 4.62 5.02 7.26 5.06 3.69 5.16 2.41 2.11 1.29 0.68
Price to Tangible BV 5.49 5.87 8.29 5.83 4.15 5.88 2.73 2.33 2.90 1.39
EV/Sales 1.39 1.57 2.21 1.47 1.17 1.52 0.77 0.79 0.60 0.23
EV/EBITDA 9.17 11.06 12.80 9.23 6.69 9.40 5.95 6.39 5.77 2.75
EV/Operating CF 10.19 13.28 17.26 12.32 8.30 14.92 7.38 10.26 8.37 9.50
EV/FCF 13.38 14.87 18.62 14.17 9.17 16.68 8.20 12.90 10.02 17.08
Quick Ratio 1.27 1.75 1.87 1.73 1.86 1.49 2.01 2.78 1.30 1.23
Current Ratio 2.01 2.41 2.64 2.42 2.53 2.27 2.67 3.52 2.00 2.24
Net Debt/EBITDA (1.16) (1.66) (1.35) (1.39) (1.57) (1.25) (2.24) (2.91) (2.05) (2.05)
Debt/Assets 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover 2.25 2.12 2.22 1.98 1.96 1.95 1.70 1.50 1.24 1.24
Operating CF/Net income 1.37 1.98 1.21 1.26 1.29 1.04 1.50 1.11 1.45 2.08
Capex/Depreciation (2.42) (0.82) (0.66) (0.72) (0.67) (0.57) (0.49) (0.71) (0.45) (0.25)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 33.01% 18.17% 33.47% 27.06% 31.43% 27.85% 16.72% 13.69% 8.17% 2.02%
ROA 22.38% 12.63% 23.51% 18.77% 21.53% 19.12% 11.81% 10.38% 6.09% 1.44%
ROIC 57.95% 71.34% 103.92% 78.17% 85.03% 68.50% 46.05% 34.88% 11.83% 6.24%
Return on Tangible Assets 41.57% 20.72% 37.60% 34.85% 34.86% 38.06% 20.50% 16.00% 17.95% 4.23%
Average Days of Receivables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 68.31% 70.22% 67.28% 68.55% 66.02% 67.29% 69.81% 70.71% 73.37% 73.49%
Intangible Assets out of Total Assets 0.11 0.10 0.09 0.09 0.08 0.08 0.08 0.07 0.40 0.36
Share Based Compensation of Revenue 1.64% 1.48% 1.26% 1.46% 1.27% 1.21% 1.33% 1.58% 1.70% 1.49%
Graham Net Nets 0.09 0.10 0.08 0.09 0.14 0.09 0.21 0.27 0.09 0.22
Graham Number 34.16 29.08 43.19 39.30 52.46 50.20 42.69 43.79 37.13 18.87
Earnings Yield 6.20% 3.36% 4.34% 5.63% 7.60% 5.64% 6.59% 6.06% 6.13% 2.80%
Free Cash Flow Yield 6.93% 6.06% 4.97% 6.19% 8.91% 5.32% 8.92% 5.36% 7.44% 3.42%
Revenue per Share 41.60 43.01 49.34 46.85 53.63 58.89 51.86 47.84 44.73 49.92
Operating CF per Share 5.66 5.08 6.31 5.60 7.58 6.02 5.40 3.67 3.19 1.21
Capex per Share (1.35) (0.54) (0.46) (0.73) (0.71) (0.63) (0.54) (0.75) (0.52) (0.54)
Free Cash Flow per Share 4.31 4.54 5.85 4.87 6.87 5.38 4.86 2.92 2.67 0.67
Cash per Share 7.27 10.15 11.53 10.37 14.74 11.90 14.98 17.16 9.52 8.54
Shareholders Equity per Share 13.45 14.92 16.23 15.53 20.88 19.61 22.57 25.83 27.85 28.76
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 13.45 14.92 16.23 15.53 20.88 19.61 22.57 25.83 27.85 28.76
Free Cash Flow 104.20 110.58 141.07 110.18 145.31 108.48 93.51 56.16 50.98 12.43
Working Capital 139.37 198.98 243.65 193.18 257.21 204.33 240.55 298.90 139.56 159.84
Capital Expenditures (32.69) (13.20) (11.05) (16.55) (15.09) (12.75) (10.39) (14.48) (10.01) (9.92)
Net Current Asset Value 132.51 184.10 229.02 164.06 226.05 182.50 222.31 282.19 63.10 78.59
EV/EBIT 10.06 12.41 13.94 10.68 7.55 10.63 7.13 7.79 7.70 5.67
Capex to Sales 0.03 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01
Net Profit Margin 9.94% 5.97% 10.61% 9.48% 10.99% 9.82% 6.94% 6.93% 4.92% 1.16%
Price to Operating Income 10.85 13.77 15.07 12.17 9.24 11.98 9.74 11.26 10.34 9.72
Other line items
Depreciation/Fixed assets 0.13 0.16 0.18 0.24 0.22 0.22 0.22 0.20 0.24 0.42
Cash ROIC 7.11% 3.43% 8.98% 5.37% 7.96% 3.06% 0.85% (3.52%) (4.70%) (10.42%)
Accounts Receivable Turnover 65.97 68.67 86.53 93.09 140.24 162.72 138.93 0.00 0.00 0.00
Accounts Payable Turnover 18.88 17.23 18.47 16.69 13.61 13.75 15.79 16.73 14.62 13.73
Inventory Turnover 2.75 2.81 2.77 2.49 2.63 2.31 2.34 2.75 2.46 2.33
Average Days of Payables 18.31 23.98 18.09 24.38 31.76 22.63 20.80 20.80 27.13 31.37
Days of Inventory on Hand 131.28 128.01 149.03 134.13 157.48 164.69 126.30 126.95 157.89 186.47
Average Receivables 15.25 15.25 13.74 11.40 8.09 7.29 7.19 — — —
Average Payables 9.54 10.41 10.87 11.24 15.36 15.85 12.28 10.56 11.03 14.62
Average Inventory 65.46 63.86 72.43 75.43 79.56 94.27 82.70 64.27 65.59 86.17
Average Assets 446.94 494.96 536.87 535.70 578.91 609.31 587.14 614.65 690.48 745.55
Average Common Equity 303.07 344.25 377.18 371.43 396.68 418.39 414.80 465.84 514.66 532.61

Fold the line items

Columns are period end dates